Startups & FundingLOT 261122 · 3 min read
Neurotech Startup Science Raises $400M as Top U.S. Megadeal of Week
Science's $400M Series D led U.S. megadeals; Isomorphic Labs' $5B topped the world. Eight U.S. rounds hit nine figures as tech stocks slid.
Key takeaways
- Science raised $400M in Series D, pushing total funding past $900M
- Isomorphic Labs secured $5B in Series C led by Greenoaks and Sequoia Capital
- Eight U.S. startups announced rounds of $100M or more this week
- Model ML closed a $250M Series B at a $1.5B valuation
- Marrow Therapeutics launched with a combined $173M across Series A and B rounds

Brain-computer interface developer Science secured $400 million in Series D funding, the largest U.S. venture round of the past week, bringing total funding for the Alameda, California company past $900 million. Seven more U.S. startups announced rounds of $100 million or more, while UK-based AI drug discovery firm Isomorphic Labs landed $5 billion — the single largest financing worldwide.
The week's private market strength stands against a rocky public backdrop. Anthropic completed its massive IPO, yet tech stocks took a sharp dive in recent days. Crunchbase analysts warn that sustained negative sentiment and downward pressure should be expected to spill over into private markets.
What did the biggest U.S. rounds bring?
The ten largest announced U.S. funding rounds break down as follows:
- Science, $400M, neurotech — brain-computer interface and neural engineering work; Series D lifts total funding above $900 million.
- Model ML, $250M, AI and fintech — Series B at a $1.5 billion valuation, led by General Atlantic and QED Investors; the company is three years old and based in New York and London.
- Galvanize Therapeutics, $130M, biotech — pulsed electric field ablation for oncology and chronic disease; Series D led by HealthQuest Capital, based in Redwood City, California.
- General Flash, $128M, critical metals — a new production method for critical metals; raised across seed and Series A rounds from a long list of investors.
- Ramon.Space, $124M, space tech — Denver developer of space computing infrastructure; Series B led by PSG.
- Marrow Therapeutics, $120M, biotech — launched with a combined $173 million; Orbimed led the $120 million Series B, while Scion Life Sciences and venBio led a $53 million Series A; based in Watertown, Massachusetts, targeting bone marrow therapies for severe blood disorders.
- Noeri, $110M, enterprise AI — self-improving AI for enterprises and researchers; Menlo Ventures led initial funding for the Palo Alto startup founded by Stanford computer science professors.
- Seawolf Therapeutics, $100M, biotech — emerged from stealth with a novel DNA delivery platform; Versant Ventures, MPM BioImpact and Novartis Venture Fund lead; based in San Diego.
- BrightAI, $97M, physical AI — sensors, drones and robotics for continuous observability of power, water and energy infrastructure; Smith Point Capital led the round for the Silicon Valley company.
- Vincue, $93M, vehicle intelligence — Kansas City developer of a vehicle lifecycle intelligence platform; growth capital led by Wavecrest Growth Partners.
Who topped the week overseas?
London-based Isomorphic Labs secured $5 billion in Series C funding, applying AI to drug discovery. Greenoaks and Sequoia Capital led the financing for the five-year-old company, which also maintains offices in Massachusetts and Switzerland. The round dwarfs every U.S. deal of the week — roughly twelve times the size of Science's headline raise.
What does the mix signal?
Biotech claimed three of the top ten U.S. slots, a reminder that life sciences remains a reliable destination for nine-figure checks. AI in its various forms — fintech, enterprise, physical and drug discovery — accounted for another four. The remainder spans critical metals, space computing and automotive software, a spread with no single theme dominating.
The public markets cast the only shadow. If the recent slide in tech shares holds, the easy money behind this week's $1.5 billion-plus U.S. total may prove harder to repeat next week.
news.crunchbase.com (Source)
More from Nathan Brooks
Show full bio
Senior reporter covering people, launches and day-to-day practice in Semiconductors, chip manufacturing, hardware, AI compute at Chip Dispatch.
1,201 articles